We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

MINDRAY In-Vitro Diagnostics

  Gold Mindray offers a range of chemistry and hematology analyzers, designed to meet the needs of smaller labs as a main in... read more Featured Products: More products

Download Mobile App





Latest Generation Immunoassay Analyzer to Be Displayed at AACC Annual Meeting

By LabMedica International staff writers
Posted on 02 Aug 2016
Print article
Image: The CL-1000i chemiluminescence immunoassay analyzer (Photo courtesy of Shenzhen Mindray Bio-Medical Electronics).
Image: The CL-1000i chemiluminescence immunoassay analyzer (Photo courtesy of Shenzhen Mindray Bio-Medical Electronics).
A large capacity, robust, yet simple-to-use chemiluminescence immunoassay analyzer will be presented at the 2016 AACC Annual Meeting & Clinical Lab Expo (Philadelphia, PA, USA).

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Shenzhen, China) will have the CL-1000i chemiluminescence immunoassay analyzer on display in Booth 2027 at the Philadelphia expo.

The CL-1000i is a robust yet simple-to-use chemiluminescence immunoassay analyzer. It offers a large capacity of 25 reagents, six sample racks, and supports non-stop replacement of reagents and consumables during testing. By integrating reliable chemiluminescence immunoassay technology with the latest in electrical and intuitive software improvements, CL-1000i reduces the complexity of laboratory operations and enhances diagnostic confidence. Currently Mindray offers 49 immunoassay tests for use with analyzer, with more to come in the near future.

Mindray has been a leading medical devices provider in the areas of patient monitoring and life support, in-vitro diagnostics, and medical imaging system for more than 25 years. In the in vitro diagnostics field, Mindray offers solutions for laboratories with different test volume requirements for hematology, biochemistry, chemiluminescence immunoassay, hemoglobin, flow cytometry, coagulation, and others.

Related Links:
AACC Annual Meeting & Clinical Lab Expo
Shenzhen Mindray Bio-Medical Electronics
Gold Supplier
SARS-CoV-2 Multiplex Real-Time RT-PCR Assay
GSD NovaPrime Plus SARS-CoV-2
New
Gold Supplier
Chemistry Analyzer
BS-600M
New
Electrolyte Analyzer
CARELYTE A-Series
New
High-Throughput Nucleic Acid Extractor
Stream SP96

Print article

Channels

Clinical Chem.

view channel
Image: The analysis pipeline used to investigate associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer’s disease (Photo courtesy of University College London)

Lipid Measurements Show Potential as Alzheimer’s Disease Biomarkers

Brain changes accompanying ageing are varied and can include pathologies that lead to cognitive impairment, the commonest of which is Alzheimer’s disease (AD). Identifying blood-based signatures of brain... Read more

Molecular Diagnostics

view channel
Image: This image depicts a DNA molecule that is methylated on both strands on the center cytosine. DNA methylation plays an important role for epigenetic gene regulation in development and cancer (Photo courtesy of Wikimedia Commons)

Study Supports Use of Methylated DNA Biomarkers for Cancer Diagnosis and Prognosis

A recent study added weight to the theory that methylated DNA biomarkers could be used for cancer diagnosis and prognosis. Methylation is a biological process by which methyl groups are added to a DNA molecule.... Read more

Hematology

view channel
Image: Standard test for multiple myeloma provides clues of a rare, more deadly type (Photo courtesy of Pexels)

Standard Blood Cancer Test Provides Clues of Rare IgD Multiple Myeloma

IgD myeloma accounts for about 1% of common blood cancer multiple myeloma and has a worse prognosis. Specific testing for IgD myeloma is available at a handful of reference labs across the US, but takes... Read more

Industry

view channel
Image: QIAGEN has acquired a majority stake in enzymes provider BLIRT S.A. (Photo courtesy of QIAGEN)

Qiagen Acquires Enzymes Provider Blirt to Strengthen Sample Technologies Business

QIAGEN N.V. (Venlo, Netherlands) has signed agreements to acquire a 96% majority ownership stake in BLIRT S.A. (Gdansk, Poland), a manufacturer of recombinant enzymes for the life science industry.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.